Blueprint: Blackstone’s $3.4bn life science deal with Brookfield, MARK hits its hard-cap, Prologis’s logistics outlook

What Blackstone’s $3.45 billion portfolio acquisition says about life science; how the firm formerly known as Meyer Bergman fared with its first fund; Prologis’s outlook on logistics demand; and more in today's briefing, exclusively for our valued subscribers.